| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $96.07K | $605.03K | $749.02K | $69.74K | $37.80K |
| R&D | – | – | – | – | – |
| SG&A | $96.07K | $605.03K | $749.02K | $70.00K | $63.06K |
| Operating Income | -$96.07K | -$605.03K | -$749.02K | -$69.74K | -$37.80K |
| Interest Expense | $497.91K | $501.27K | $498.12K | $513.67K | $532.02K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $286.66K | -$1.11M | -$1.25M | -$435.38K | -$569.78K |
| EPS (basic) | 0.0000 | -0.0100 | -0.0100 | -0.0100 | – |
| EPS (diluted) | 0.0000 | -0.0100 | -0.0100 | -0.0100 | – |
| Shares (diluted) | $110.97M | $110.78M | $110.53M | $110.41M | – |